Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Etidronate].

Kentaro Inui1, Kunio Takaoka

  • 1Department of Orthopaedic Surgery, Osaka City University Medical School.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|March 18, 2003
PubMed
Summary
This summary is machine-generated.

Cyclical etidronate therapy effectively increases bone density and reduces fractures in osteoporosis patients. This safe and well-tolerated treatment offers benefits comparable to other bisphosphonates with easier patient compliance.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Age-related differences in MRI signal intensity of the quadriceps and patellar tendons: Implications for ACL graft selection.

Journal of experimental orthopaedics·2026
Same author

Comparison of Knee Bone Morphology and Accessory Ossicle Incidence Between Elite Male Soccer Players and Controls.

Orthopaedic journal of sports medicine·2025
Same author

Correction: Toward mapping pragmatic impairment of autism spectrum disorder individuals through the development of a corpus of spoken Japanese.

PloS one·2025
Same author

Massive Osteolysis of the Femur (Gorham-Stout Disease) Requiring Total Femur Replacement: A Case Report.

JBJS case connector·2025
Same author

Change of autoantibody levels in established rheumatoid arthritis patients treated by biological disease-modifying anti-rheumatic drugs -the AIRTIGHT study.

Journal of rheumatic diseases·2025
Same author

Correction: Toward mapping pragmatic impairment of autism spectrum disorder individuals through the development of a corpus of spoken Japanese.

PloS one·2025

Area of Science:

  • Endocrinology
  • Bone Metabolism
  • Pharmacology

Context:

  • Postmenopausal osteoporosis and steroid-induced osteoporosis are significant health concerns.
  • Bisphosphonates are a key therapeutic class for managing bone loss.
  • Etidronate, while less potent, offers therapeutic benefits through intermittent dosing.

Purpose:

  • To evaluate the efficacy and safety of intermittent cyclical etidronate therapy.
  • To assess the impact of etidronate on bone mineral density and fracture incidence.
  • To compare the therapeutic profile of etidronate with other bisphosphonates.

Summary:

  • Intermittent cyclical etidronate therapy demonstrated significant increases in bone mineral density (BMD) in the spine and hip.
  • The treatment regimen led to a reduced incidence of new vertebral fractures in women with postmenopausal and steroid-induced osteoporosis.

Related Experiment Videos

  • Seven-year treatment data indicated that etidronate is safe, effective, and well-tolerated, with additive BMD effects when combined with hormone replacement therapy.

    • Impact:

    • Cyclical etidronate therapy provides a valuable, patient-friendly option for osteoporosis management.
    • The intermittent dosing strategy enhances compliance and minimizes adverse events compared to continuous bisphosphonate use.
    • This approach remains a clinically relevant strategy for improving bone health and preventing fractures in at-risk populations.